Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis ; volume:04 ; number:03 ; year:2020 ; pages:e245-e254
TH open ; 04, Heft 03 (2020), e245-e254
- Contributor
-
van Hout, Ben
Hawe, Emma
Cohen, Alexander T.
- DOI
-
10.1055/s-0040-1716496
- URN
-
urn:nbn:de:101:1-2020121710182160645983
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van Hout, Ben
- Hawe, Emma
- Cohen, Alexander T.
Other Objects (12)
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort
Protocol for a systematic review of prognostic models for the recurrence of venous thromboembolism (VTE) following treatment for a first unprovoked VTE
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE
Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study
SEOM clinical guideline of venous thromboembolism (VTE) and cancer (2019)
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023)
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
Venous thromboembolism (VTE) prophylaxis in severely injured patients: an international comparative assessment
Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trial
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE Europe
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort
Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort